On April 4, 2023, Khiron Life Sciences Corp. ("Khiron") (TSXV: KHRN) (OTCQX: KHRNF) announced that it had closed its previously announced marketed public offering of units, including the exercise in full of the over-allotment option, for aggregate gross proceeds of $690,000. The offering was led by Canaccord Genuity Corp. as agent and sole bookrunner.

Khiron is a leading global medical cannabis company with core operations in Latin America and Europe. 
 
Gowling WLG was counsel to Khiron in this transaction with a team that included Peter Simeon, Jacob Cawker and Ashley Andaya.